echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > What is the salary of the CEO of the world's top 20 pharmaceutical giants by market value?

    What is the salary of the CEO of the world's top 20 pharmaceutical giants by market value?

    • Last Update: 2021-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CompilationFan Dongdong

    The executives of pharmaceutical companies are usually known for their high incomes.
    If bonuses and stock options are also taken into account, the annual salary of the CEOs of pharmaceutical giants can generally reach tens of millions of dollars, such as Pfizer's Albert Bourla and Johnson & Johnson's Alex Gorsky and Pascal Soriot of AstraZeneca.

    In the past few weeks, life sciences and biopharmaceutical companies have successively announced year-end financial reports, including the total compensation of the CEO and other members of the executive team in 2020.
    Among them, the annual salary of CEOs of companies involved in the development of COVID-19 vaccines has increased.
    [Related reading: The
    salary of the CEO of the new crown vaccine manufacturer has soared! Pfizer, BioNTech, Johnson & Johnson.
    .
    .

    The salary of the CEO of the new crown vaccine manufacturer has risen! Pfizer, BioNTech, Johnson & Johnson.
    .
    .

    According to the data released by the top 20 biopharmaceutical companies by market capitalization, the latest basic salary information of the CEOs of each company is collected and compiled.
    The salary range is very large, from the lowest Vertex CEO David DeStefano's $591,710 to the highest Swiss pharmaceutical giant Roche CEO Severin Schwan's $3,785,000.

    Most of the increase in the amount is in the form of bonuses and stock options.
    For example, Ugur Sahin, CEO of BioNTech in Germany, received US$7.
    4 million through stock options.
    In addition to the basic salary, it is worth paying attention to the changes in this year's salary compared with the previous year's basic salary.

    The salary of some CEOs this year only increased by a few percentage points year-on-year.
    However, the basic salary of Novartis CEO Vas Narasimhan and Gilead CEO Daniel O'Day increased significantly by 29.
    8% and 34.
    4%, respectively.
    This may be due to Remdesivir.
    Caused by the early success of the COVID-19 pandemic.
    In addition, the basic salary of two CEOs has fallen.
    Roche Schwan’s basic salary was the highest, a decrease of 12.
    5% ​​from 2019.
    Illumina CEO Francis deSouza’s basic salary dropped by 2.
    1%.

    If shareholder approval is obtained later this month, Johnson & Johnson CEO Alex Gorsky’s total compensation will be increased to $30 million.
    However, opposition voices within the company believe that Gorsky should be responsible for litigation related to the opioid business and does not support a salary increase under the condition of causing billions of dollars in losses to the company.

    Although Teva, the Israeli-based generic drug giant, is not on the list of the top 20 pharmaceutical companies by market capitalization, its CEO, Kåre Schultz, is expected to significantly increase its annual salary.
    Although the base salary of US$2 million is the same as in 2019, Schultz’s stock holdings will increase by US$4 million, an increase of as much as 35%.

    The following is based on the data released by the top 20 biopharmaceutical companies ranked by market capitalization, the basic salary table of CEOs prepared:

    Reference source: CEO Salaries for the Top 20 Pharma Companies by Market Cap

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.